TMCnet News
T2 Biosystems to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceLEXINGTON, Mass., Feb. 21, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, president and chief executive officer, is scheduled to present at the 8th Annual SVB Leerink Global Healthcare Conference. The conference is being held February 27 – March 1 in New York City. Mr. McDonough is scheduled to present on Thursday, February 28, 2019 at 2:00 p.m. ET. Mr. McDonough and John Sprague, chief financial officer, will be available for one-on-one meetings during the conference. The presentation will be webcast live and available for replay, and may be accessed by visiting the Investors/Events & Presentations section of the Company’s website at www.t2biosystems.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 90 days following the presentation. About T2 Biosystems: Media Contact: Investor Contact: |